Cargando…
Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
SARS-CoV-2 infections elicit a humoral immune response capable of neutralising the virus. However, multiple variants have emerged with mutations in the spike protein amongst others, the key target of neutralising antibodies. We evaluated the neutralising efficacy of 89 serum samples from patients, i...
Autores principales: | Müller, Katharina, Girl, Philipp, Giebl, Andreas, Gruetzner, Stefanie, Antwerpen, Markus, Khatamzas, Elham, Wölfel, Roman, von Buttlar, Heiner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489549/ https://www.ncbi.nlm.nih.gov/pubmed/34608598 http://dx.doi.org/10.1007/s11262-021-01871-8 |
Ejemplares similares
-
Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
por: Müller, Katharina, et al.
Publicado: (2021) -
Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2
por: Müller, Katharina, et al.
Publicado: (2021) -
Side-By-Side Evaluation of Three Commercial ELISAs for the Quantification of SARS-CoV-2 IgG Antibodies
por: Girl, Philipp, et al.
Publicado: (2022) -
Evaluation of Two Rapid Lateral Flow Tests and Two Surrogate ELISAs for the Detection of SARS-CoV-2 Specific Neutralizing Antibodies
por: Girl, Philipp, et al.
Publicado: (2022) -
SARS-CoV-2 Seroprevalence among Health Care Workers—A Voluntary Screening Study in a Regional Medical Center in Southern Germany
por: Müller, Katharina, et al.
Publicado: (2021)